An italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
MediaPharma S.r.l.
A Company focused on the discovery, development and commercialization of monoclonal antibodies for the diagnosis and treatment of cancer and other diseases with unmet medical need.
The Company, established in 2009 as a spin-off of the "G. d'Annunzio" University Foundation, is based in Chieti, Italy.
Last updated: 26/05/2010 16:04
News
-
MediaPharma has established the Scientific Advisory Board
Updated | 27/04/2010 16:04 -
MediaPharma on Tg Leonardo
RAI TG Leonardo interviews Prof. S. Iacobelli, Founder and President of MediaPharma
Updated | 15/03/2010 15:03 -
MediaPharma wins the semi-final of the European Venture Contest in Turin!
Updated | 24/11/2009 14:02
Subscribe to Rss Feed
ShareMediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
